Literature DB >> 2562826

Growth hormone-releasing factor-sensitive adenylate cyclase system of purified somatotrophs: effects of guanine nucleotides, somatostatin, calcium, and magnesium.

N Narayanan1, B Lussier, M French, B Moor, J Kraicer.   

Abstract

The purpose of this study was to characterize the adenylate cyclase system in a purified population of normal somatotrophs derived from rat pituitary and to determine the responses of this system to GRF, somatostatin, guanine nucleotides, and cations. Additionally, experiments were performed to evaluate the interrelationships among changes in adenylate cyclase activity, cellular cAMP levels, and GH release induced by GRF and somatostatin. The results obtained using homogenates and membrane preparations from somatotrophs included the following. 1) GRF caused guanine nucleotide-dependent concentration-related (Ka, approximately 10(-8) M) stimulation of adenylate cyclase activity. 2) Guanine nucleotides were effective in stimulating cyclase in the absence of GRF; the concentration of guanine nucleotide required for half-maximal stimulation was decreased more than 10-fold in the presence of GRF. 3) Adenylate cyclase activity increased with increasing concentrations of free Mg2+ (0.25-20 mM); activation by GRF and guanine nucleotide resulted in an approximately 7-fold increase in the enzyme's affinity for free Mg2+. 4) Somatostatin, up to 10(-6) M, did not alter basal or GRF-stimulated adenylate cyclase activity. 5) Ca2+ (0.5-11.9 microM) produced concentration-dependent inhibition of basal (up to 28%) and GRF-stimulated (up to 47%) cyclase activities; the inhibitory effect of Ca2+ was accompanied by a decrement (2- to 3-fold) in the apparent affinities of the enzyme for both GRF and guanine nucleotide. In intact somatotrophs, GRF produced concentration-dependent stimulation of GH release (Ka, approximately 6 x 10(-11) M), preceded by a marked elevation of cAMP levels. While somatostatin blocked GRF-induced GH release, the augmented cAMP levels were only slightly reduced.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2562826     DOI: 10.1210/endo-124-1-484

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  Inhibition of adenylate cyclase by Ca(2+)--a counterpart to stimulation by Ca2+/calmodulin.

Authors:  D M Cooper
Journal:  Biochem J       Date:  1991-09-15       Impact factor: 3.857

2.  Predominant expression of type-VI adenylate cyclase in C6-2B rat glioma cells may account for inhibition of cyclic AMP accumulation by calcium.

Authors:  M A Debernardi; R Munshi; M Yoshimura; D M Cooper; G Brooker
Journal:  Biochem J       Date:  1993-07-15       Impact factor: 3.857

3.  Supra-additive activation of guinea-pig superior cervical ganglion adenylate cyclase by PGE2 and D-Ala2-Met-enkephalinamide: role of GTP.

Authors:  C Biondi; P G Borasio; M E Ferretti; M C Pareschi
Journal:  Neurochem Res       Date:  1990-08       Impact factor: 3.996

4.  Somatostatin-induced control of cytosolic free calcium in pituitary tumour cells.

Authors:  C Petrucci; D Cervia; M Buzzi; C Biondi; P Bagnoli
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

5.  Growth hormone-releasing hormone stimulates cAMP release in superfused rat pituitary cells.

Authors:  J E Horváth; K Groot; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

6.  Cloning and expression of a Ca(2+)-inhibitable adenylyl cyclase from NCB-20 cells.

Authors:  M Yoshimura; D M Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

7.  Digoxin reduces beta-adrenergic contractile response in rabbit hearts. Ca(2+)-dependent inhibition of adenylyl cyclase activity via Na+/Ca2+ exchange.

Authors:  K Nagai; T Murakami; T Iwase; T Tomita; S Sasayama
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

8.  Morphological effects of somatostatin on rat somatotrophs previously activated by growth hormone-releasing factor.

Authors:  O Shimada; H Tosaka-Shimada; H Ishikawa
Journal:  Cell Tissue Res       Date:  1990-08       Impact factor: 5.249

9.  Stimulation of mitogen-activated protein kinase pathway in rat somatotrophs by growth hormone-releasing hormone.

Authors:  P Zeitler; G Siriwardana
Journal:  Endocrine       Date:  2000-06       Impact factor: 3.925

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.